MENU
ASK US ANYTHING

Products

green and blue background with heartbeat line

Fast, Continuous UV-C Air Purification

 

VidaShield UV24 is a fast, 24/7, active air purification system that uses UV-C to reduce bacteria and fungi from the air. This patented device is uniquely designed by combining an ultraviolet germicidal irradiation (UVGI) chamber and air circulating fans with an overhead ceiling light. No engineering controls are needed to operate VidaShield UV24. Simply wire it up, plug it in and you are on your way to treating the air.

VidaShield UV24 reduces the levels of bacteria and fungi in treated air and reduces the settling of viable bacteria and fungi from treated air on surfaces. The innovative design allows for 24/7 operation in occupied spaces. The system can treat a volume of air equivalent to an 8’ x 10’ x 10’ room four times per hour. Conveniently installed in ceilings, VidaShield UV24 is an unobtrusive space saver.

VS01

VS01 (Fluorescent)

• Fluorescent or LED tubes
• 24” wide x 48” long x 6” high (UV chamber included)
• 44 lbs.
• 50-57 watts
• 120-277 voltage, 347 VAC
• T8 ballast configuration with options
• Antimicrobial powder coat finish
• 4,000 lumens (fluorescent), 3500 lumens (LED)
• Dedicated UV ballast
• Ultra-quiet air circulation fans
• 50 CFM air volume
• MERV 6 high flow air particle filter
• Formed baffles prevent UV light leaks
• Safety switch deactivates UV when accessed

VS02

VS02 (LED)

• LED panel
• 24” wide x 48” long x 6” high (UV chamber included)
• 42 lbs.
• 60 watts
• 120-277 voltage, 347 VAC
• 0-10v Dimming
• Antimicrobial powder coat finish
• 7,200 lumens
• Dedicated UV ballast
• Ultra-quiet air circulation fans
• 50 CFM air volume
• MERV 6 high flow air particle filter
• Formed baffles prevent UV light leaks
• Safety switch deactivates UV when accessed

VS03

VS03 (No Downlight)

• No downlight
• 24” wide x 48” long x 6” high (UV chamber included)
• 41 lbs.
• 120-277 voltage, 347 VAC
• Antimicrobial powder coat finish
• Standard pattern acoustical tile
• Dedicated UV ballast
• Ultra-quiet air circulation fans
• 50 CFM air volume
• MERV 6 high flow air particle filter
• Formed baffles prevent UV light leaks
• Safety switch deactivates UV when accessed

VidaShield systems are also available in European versions. See specification sheets for detail

Specification Registration

Download the Specification Registration form to register your project with the VidaShield team. Email completed form to questions@vidashield.com.

DOWNLOAD SPECIFICATION REGISTRATION FORM

Benefits

Healthcare staff who conducted a study at a Long Term Acute Care Hospital reported an overall reduction in infections of 53%, a reduction in healthcare odors, improved indoor air quality and better lighting1.

bacteria icon

REDUCES
BACTERIA

filters icon

REDUCES
SETTLING

time icon

CLEANS
24/7 by 365

arrows icon

SAVES
SPACE

gear icon

MINIMAL
MAINTENANCE

checkbox

IMPROVES IAQ

WHERE SHOULD VIDASHIELD UV24 BE INSTALLED?

High risk patients, high contamination and high-density areas

 

Patients with suppressed or compromised immune systems due to advanced or premature age, disease or illness are susceptible to pathogen aerosols that can cause infections. Those infections can have dangerous, even deadly consequences. Research studies show that hospital air can be a route of transmission for pathogen aerosols that can contribute to infections.2

 

VidaShield UV24 is designed for use in hospitals, long term care facilities, nursing homes, schools, commercial office buildings and any other location where cleaner environmental air is desired.

 

 

 

EPA Establishment Number No. 94728-CA-1.
This product is protected by US Patent Numbers: 8,350,228; 7,922,351; and 8,439,517; as well as, protected by the corresponding foreign protection.

1Long Term Acute Care Hospital, Kentucky (VidaShield UV24 is not intended to treat HAIs and does not claim to reduce HAIs.)
2Seyed Hamed Mirhoseini PhD, Mahnaz Nikaeen PhD, Zahra Shamsizadeh MS, Hossein Khanahmad PhD. (2016) Hospital air: A potential route for transmission of infections caused by β-lactam–resistant bacteria, American Journal of Infection Control doi:10.1016/j.ajic.2016.01.041